Survival in bladder and upper urinary tract cancers in Finland and Sweden through 50 years.

Survival in bladder and upper urinary tract cancers in Finland and Sweden through 50 years.

Показать другие версии (1)

Survival has improved in bladder cancer but few studies have considered extended periods or covered populations for which medical care is essentially free of charge. We analyzed survival in urothelial cancer (UC, of which vast majority are bladder cancers) in Finland and Sweden over a 50-year period...

Полное описание

Библиографические подробности
Главные авторы:	Kari Hemminki, Asta Försti, Akseli Hemminki, Börje Ljungberg, Otto Hemminki
Формат:	Статья
Язык:	English
Опубликовано:	Public Library of Science (PLoS) 2022-01-01
Серии:	PLoS ONE
Online-ссылка:	https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0261124&type=printable

Схожие документы

Survival in bladder and upper urinary tract cancers in Finland and Sweden through 50 years
по: Kari Hemminki, и др.
Опубликовано: (2022-01-01)

Progress in survival in renal cell carcinoma through 50 years evaluated in Finland and Sweden.
по: Kari Hemminki, и др.
Опубликовано: (2021-01-01)

Survival in colon and rectal cancers in Finland and Sweden through 50 years
по: Akseli Hemminki, и др.
Опубликовано: (2021-10-01)

Incidence trends in bladder and lung cancers between Denmark, Finland and Sweden may implicate oral tobacco (snuff/snus) as a possible risk factor
по: Kari Hemminki, и др.
Опубликовано: (2021-05-01)

Cervical, vaginal and vulvar cancer incidence and survival trends in Denmark, Finland, Norway and Sweden with implications to treatment
по: Kari Hemminki, и др.
Опубликовано: (2022-04-01)

Incidence and survival in laryngeal and lung cancers in Finland and Sweden through a half century.
по: Anni Koskinen, и др.
Опубликовано: (2022-01-01)

Bladder and upper urinary tract cancers as first and second primary cancers
по: Guoqiao Zheng, и др.
Опубликовано: (2021-12-01)

Critical survival periods in prostate cancer in Sweden explored by conditional survival analysis
по: Kari Hemminki, и др.
Опубликовано: (2024-04-01)

Survival, Incidence, and Mortality Trends in Female Cancers in the Nordic Countries
по: Filip Tichanek, и др.
Опубликовано: (2023-01-01)

Survival in gastric and esophageal cancers in the Nordic countries through a half century
по: Kari Hemminki, и др.
Опубликовано: (2023-05-01)

Long-term survival trends for primary liver and pancreatic cancers in the Nordic countries
по: Kari Hemminki, и др.
Опубликовано: (2022-12-01)

Conditional survival in breast cancer up to 10 years in the Nordic countries
по: Frantisek Zitricky, и др.
Опубликовано: (2023-09-01)

Survival trends in hematological malignancies in the Nordic countries through 50 years
по: Kari Hemminki, и др.
Опубликовано: (2022-11-01)

Survival improvements in esophageal and gastric cancers in the Nordic countries favor younger patients
по: Kari Hemminki, и др.
Опубликовано: (2024-08-01)

High familial risks in some rare cancers may pinpoint to hidden germline genetics: focus on esophageal, stomach, small intestinal, testis, thyroid and bone cancers
по: Kari Hemminki, и др.
Опубликовано: (2025-02-01)

Survival in oral and pharyngeal cancers is catching up with laryngeal cancer in the NORDIC countries through a half century
по: Frantisek Zitricky, и др.
Опубликовано: (2024-01-01)

Age-specific familial risks in cancer as clues to germline genetic and environmental causes: focus on colorectal, endometrial, prostate, kidney, breast and lung cancers
по: Kari Hemminki, и др.
Опубликовано: (2025-02-01)

Incidence, mortality and survival in multiple myeloma compared to other hematopoietic neoplasms in Sweden up to year 2016
по: Kari Hemminki, и др.
Опубликовано: (2021-08-01)

Incidence and survival in non-hereditary amyloidosis in Sweden
по: Hemminki Kari, и др.
Опубликовано: (2012-11-01)

Familial risks in and between stone diseases: sialolithiasis, urolithiasis and cholelithiasis in the population of Sweden
по: Kari Hemminki, и др.
Опубликовано: (2018-07-01)

Rate differences between first and second primary cancers may outline immune dysfunction as a key risk factor
по: Guoqiao Zheng, и др.
Опубликовано: (2020-11-01)

Epidemiology of Amyloidosis and Genetic Pathways to Diagnosis and Typing
по: Kari Hemminki, и др.
Опубликовано: (2021-07-01)

Family history of any cancer for childhood leukemia patients in Sweden
по: Xinjun Li, и др.
Опубликовано: (2021-08-01)

Survival in Thyroid Cancer in Sweden From 1999 To 2018
по: Zitricky F, и др.
Опубликовано: (2024-10-01)

Second cancers and causes of death in patients with testicular cancer in Sweden.
по: Luyao Zhang, и др.
Опубликовано: (2019-01-01)

Comparison of survival of patients with metastases from known versus unknown primaries: survival in metastatic cancer
по: Riihimäki Matias, и др.
Опубликовано: (2013-01-01)

Prostate cancer survivors: Risk and mortality in second primary cancers
по: Subhayan Chattopadhyay, и др.
Опубликовано: (2018-11-01)

Surveillance Bias in Cancer Risk After Unrelated Medical Conditions: Example Urolithiasis
по: Kari Hemminki, и др.
Опубликовано: (2017-08-01)

Survival in Lung Cancer in the Nordic Countries Through A Half Century
по: Tichanek F, и др.
Опубликовано: (2023-05-01)

Survival in common cancers defined by risk and survival of family members
по: Jianguang Ji, и др.
Опубликовано: (2011-10-01)

Familial risks between Graves disease and Hashimoto thyroiditis and other autoimmune diseases in the population of Sweden
по: Hauke Thomsen, и др.
Опубликовано: (2020-01-01)

Second Primary Cancers After Kidney Cancers, and Kidney Cancers as Second Primary Cancers
по: Guoqiao Zheng, и др.
Опубликовано: (2021-02-01)

Familial Associations of Colorectal Cancer with Other Cancers
по: Hongyao Yu, и др.
Опубликовано: (2017-07-01)

Oncolytic viruses for cancer immunotherapy
по: Otto Hemminki, и др.
Опубликовано: (2020-06-01)

The 'common disease-common variant' hypothesis and familial risks.
по: Kari Hemminki, и др.
Опубликовано: (2008-01-01)

Oncolytic Immunotherapy: Where Are We Clinically?
по: Akseli Hemminki
Опубликовано: (2014-01-01)

Portrait of a Leader in Immunotherapeutics<subtitle>Oncolytic viruses for treatment of cancer</subtitle>
по: Akseli Hemminki
Опубликовано: (2012-08-01)

TILT Biotherapeutics
по: Akseli Hemminki
Опубликовано: (2017-05-01)

Treatment of Advanced Renal Cell Carcinoma: Immunotherapies Have Demonstrated Overall Survival Benefits While Targeted Therapies Have Not
по: Otto Hemminki, и др.
Опубликовано: (2020-12-01)

Are population level familial risks and germline genetics meeting each other?
по: Kari Hemminki, и др.
Опубликовано: (2023-03-01)